Navigation Links
Texas Oncology-Baylor Sammons Cancer Center Recognized for Highest Commitment to Clinical Research at ASCO
Date:6/9/2008

HOUSTON, June 9 /PRNewswire/ -- Texas Oncology-Baylor Charles A. Sammons Cancer Center, a member of the US Oncology network, received a Clinical Trial Participation Award at the recent 44th American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The practice was one of only 10 community oncology practices to receive the award.

This is the fifth consecutive year that practices affiliated with US Oncology have been recognized for their contributions to cancer research. Since the initiation of the award in 2003, 12 US Oncology affiliated practices have won the award from ASCO.

Award winners were selected based on a number of factors including patient accrual to clinical trials over a three-year period. Special consideration was given to practices that increased clinical trials participation among underrepresented populations as well as practices that used innovative techniques to overcome barriers to enrolling patients in clinical trials.

"As a part of the US Oncology Research Network, Texas Oncology, and particularly the Baylor Sammons Cancer Center, is making significant contributions to cancer research," said Patricia Winger, vice president of research for US Oncology. "We are honored to have such distinguished practices within our network that are committed to helping advance the latest therapies through clinical research. Providing increased access to an array of treatment opportunities for patients within the community setting embodies our research mission."

Texas Oncology, a pioneer in community-based cancer care, is the largest independent oncology practice nationwide. Research site leader Joanne L. Blum, M.D., Ph.D., F.A.C.P. accepted the award on behalf of the practice.

The US Oncology Research network is an established community-based research operation specializing in all phases of cancer clinical trials. The research network currently has 595 physicians actively enrolling patients, 109 research site
'/>"/>

SOURCE US Oncology, Inc.
Copyright©2008 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2

Related biology technology :

1. Blue Cross and Blue Shield of Texas Launches an Integrated Medical-Dental Health Program
2. For creating new field of science, Texas chemist wins international prize
3. Texas Boy Receives Wheelchair From New Hampshire Couples Recently Deceased Granddaughter
4. CEL-SCI CORPORATION Manufacturing Facility for Pivotal Phase III Cancer Trial Scheduled to Be Completed During 2008 Third Quarter
5. DermTech Names Herbert A. Fritsche, Ph.D., Chief of Clinical Chemistry at M.D. Anderson Cancer Center to Companys Scientific Advisory Board
6. Monogram Announces Presentation of Clinical Data for the HERmark(TM) Breast Cancer Assay at the 44th ASCO Annual Meeting
7. Genomic Health Announces Expansion of Oncotype DX(R) Breast Cancer Test to Include Quantitative Estrogen Receptor (ER) and Progesterone Receptor (PR) Scores
8. Peregrine Pharmaceuticals Presents Promising Phase I Data at ASCO and Provides Clinical Update on Its Phase II Bavituximab Breast Cancer Study
9. Roche Signs Exclusive Distribution Deal with DxS for K-RAS and EGFR Cancer Mutation Tests
10. MammaPrint(R) Breast Cancer Test Provides Valuable Insight for Personalized Treatment Decisions
11. Ipsogen Launches MapQuant Dx(TM) Genomic Grade Test to Identify Breast Cancer Patients who Benefit From Chemotherapy

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... Health care employment grew by 29,000 jobs... show consistent growth during the U.S. recession....n trouble, and health systems are coming closer to... of just administrators. , ...ent continued growing in October despite the shedd...
(Date:11/24/2009)...24/PRNewswire/--BlueMarbleEnergyCorp.announcedtoda...ity(OPDA)wererecentlyawarded$2millionbyWashingtonS...aprivate/publicpartnershiptoconstructthestate,sfir...A. ,, "Thisinvestmentwillsignificantlyspeedthed...oLincolnCounty,"saidBlueMarbleEnergyCEOKellyOgilvi...
(Date:11/24/2009)....24,2009/PRNewswire-FirstCall/--ArenaPharmaceutica...nyisscheduledtopresentatthePiperJaffray21stAnnualH...ernTime(8:30a.m.PacificTime)attheNewYorkPalaceHote...ExecutiveOfficer,isscheduledtoprovideanoverviewoft...eryprograms. ,, Aliveaudiowebcastofthepresentat...
(Date:11/24/2009)...24/PRNewswire-FirstCall/--CellTherapeutics,Inc.(CT...tAnnualPiperJaffrayHealthCareConference.Theconfere...tel. ,, CTIwillpresentonTuesday,December1at11:0...astofCTI,spresentationwillbeavailableat www.cellth...fterwards. , ,PiperJaffrayHealthCareConference,Ne...
Breaking Biology Technology:The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Arena Pharmaceuticals to Present at the Piper Jaffray 21st Annual Health Care Conference 2
...., March 31 Watson Pharmaceuticals, Inc. (NYSE: ..., announced today that the United States District ...Watson,s generic version of Concerta (methylphenid...ot infringe United States Patent No. 6,919,373 (th.... The opinion, dated March 30, 2009, was issued b...
...ologics announces the filing of two important prov...h 31 Quantum Immunologics, Inc. (QI), a Florida-b... has recently filed two provisional patent applica...py. , , The company,s research is focused on the...cifically, iLRP - immature Laminin Receptor Protei...
...March 31 ArunA Biomedical, Inc., a leader in huma...today that it has been awarded a Department of Def...r utilizing its human stem cell technology. , ,...080819/CLTU003LOGO ) , , The company will furth...lular model for use in a prototype biosensor devel...
Other Biology Technology:Delaware Court Rules That Watson Does Not Infringe Patent Related to Generic Version of Concerta(R) and Declares Patent Invalid 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 2Immunotherapy-Based Provisional Patents Mark Significant Discovery 3ArunA Biomedical Awarded Department of Defense Contract to Further Develop Environmental Biosensor for National Security 2
(Date:11/23/2009)... University of Alabama at Birmingham (UAB) researc...ing medical conditions (co-morbidity) do not expla...mericans compared to Caucasians who also have colo... Cancer , a journal of the American Cancer Societ... co-morbidity are independent predictors of poor s...
(Date:11/23/2009)... existed for 360 million years and survived when t...hreatening to make many of them extinct, according...ogy Today . , The fungus, Batrachochytrium den...waves of amphibian extinctions in Central America ...cts over 350 amphibian species by penetrating thei...
(Date:11/23/2009)...ronmental irritants such as air pollution and ciga...lished today in the American Journal of Respirato... study, from Imperial College London and the Unive... the lungs that can trigger coughing when a person...ey suggest that their findings may ultimately lead...
Breaking Biology News(10 mins):Racial disparity in colon cancer survival not easily explained, UAB researchers say 2Research reveals exactly how coughing is triggered by environmental irritants 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 1AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 2AEterna Zentaris Receives US 245 5 Million from Institutional Investors 14577 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 1Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 2Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 3Gauze based NPWT Capable of Achieving Same Treatment Goals as Foam based NPWT 5665 4Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 1Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 2Governor Rendell Says Hundreds of Jobs Coming to York County as Medical Device Manufacturer Prepares to Expand 5662 3
...to resist the effects of cheap and popular antivir...tionary tale about U.S. plans to use the antiviral...ction in humans, scientists say. , Researchers an...nza strains to document where and when the virus d...called adamantanes and how far resistant strains s...
...xposed to low temperatures develop more blood vess...t more quickly, according to a new study from Karo...w to control blood vessel development in humans in...th of fat cells and their metabolism depend on oxy...egulate the amount of body fat in order, for inst...
...more efficient that exploits the inertia of a wind...d speed variation, according to research published...s . , Wind power is being touted as a clean and i...he wind is intermittent and so the power output of...smooth these power fluctuations usually involve th...
Other Biology News:Study: Excessive use of antiviral drugs could aid deadly flu 2Study: Excessive use of antiviral drugs could aid deadly flu 3Study: Excessive use of antiviral drugs could aid deadly flu 4Study: Excessive use of antiviral drugs could aid deadly flu 5Tilting at wind farms 2
...g and positioning system is designed for applicati...canned with high velocity and high resolution. It ...positioners with conventional leadscrew drives. Th...rated, non-contact, zero-friction, voice-coil actu...
Microarray Spotting Solution for Silane Coated Slides from Sigma-Aldrich
...y wells in the base hold 10 l of water to maintain...dges of the coverslip. The watertight seal elimina...ber can be used with either constant temperature w...S number is a new product number, created to easil...
Eppendorf MicroDissector from Eppendorf North America
Biology Products: